Examples of using Inducer in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
Inducer activated.
It's a fine sleep inducer.
Inducer increasing.
Phenytoin(CYP2C9 substrate and potent CYP450 inducer).
Inducer(see section 4.3).
Ritonavir(potent CYP450 inducer; CYP3A4 inhibitor and substrate).
The device he took with him, that was his electrostatic inducer.
Let's hope the null pulse inducer delays the signals in the trigger.
Decrease dose back to the usual recommended dose if inducer discontinued.
Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450(CYP450) enzymes(see section 5.2).
Aprepitant(125 mg/ 80 mg) is a substrate,a moderate inhibitor, and an inducer of CYP3A4.
The concomitant use of avanafil and a CYP inducer is not recommended as it may decrease the efficacy of avanafil.
A clinical monitoring should be made when both active substances are combined and,eventually a dosage adjustment during the combination and one week after the inducer treatment.
Results showed that Biobran MGN-3 is a potent TNF-α inducer and the effect was dose-dependent.
Cycloferon"- interferon inducer, immunostimulant, prevents herpetic infection, contra-indications include pregnancy or lactation;
Yeah, this and the printed circuit board from your P.D.A. Andwe can make a null pulse inducer to delay the trigger signal in the land mine.
Enzalutamide is a potent enzyme inducer and may lead to loss of efficacy of many commonly used medicinal products(see examples in section 4.5).
The potential for interaction of glycerol phenylbutyrate as a CYP3A4 inducer and those products predominantly metabolised by the CYP3A4 pathway is possible.
Training The inducer in the dog pee pad is great for training little dogs or assisting aging dogs, or as an alternative to the outdoors for indoor dogs.
It is a useful marker for distinguishing helper/inducer T-lymphocytes, and most peripheral T-cell lymphomas are CD4+/CD8-.
Inducers of cytochromes P450: Rifampicin(600 mg daily), a potent inducer of CYP3A and CYP2B6, and an inducer of CYP2C9, CYP2C19, and CYP2C8, did not significantly change the pharmacokinetics of prasugrel.
Anidulafungin is not a clinically relevant substrate, inducer, or inhibitor of cytochrome P450 isoenzymes(1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 3A).
This product is a CYP3A4 inducer, which reduces the blood concentration of cyclosporine by 50% and also reduces the plasma concentration of theophylline.
If co-administration of a moderate CYP3A4 and/or PgP inhibitor or inducer cannot be avoided, dose adjustments of Votubia may be required(see section 4.5).
Rifampicin is a strong CYP3A4 inducer and has been shown to cause a 92% decrease in indinavir AUC which can result in virological failure and resistance development.
Contrary to a treatment of several days with an inducer, a short-term treatment is expected to result in less apparent DDI with midazolam.
Rifampicin is a strong CYP3A4 inducer and has been shown to cause an 82% decrease in amprenavir AUC, which can result in virological failure and resistance development.
Co-administration of strong cytochrome P450 3A4(CYP3A4) enzyme inducer, rifampicin, resulted in a reduction of systemic exposure of apremilast, which may result in a loss of efficacy of apremilast.
Rifampicin(600 mg daily), a potent inducer of CYP3A and CYP2B6, and an inducer of CYP2C9, CYP2C19, and CYP2C8, did not significantly change the pharmacokinetics of prasugrel.
Rifampicin: Pre-dosing of the probe inducer rifampicin at a dose of 600 mg once daily for 7 days decreased total dabigatran peak and total exposure by 65.5 and 67%, respectively.